Back
Forte Biosciences Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
26
FBRX
Forte Biosciences
Last Price:
$12.10
Seasonality Move:
13.78%
Sell
43
NBY
NovaBay Pharmaceuticals
Last Price:
$0.64
Seasonality Move:
-3.26%
Sell
26
Forte Biosciences (FBRX)
is a Sell
Is Forte Biosciences a Buy, Sell or Hold?
-
The current Forte Biosciences [FBRX] share price is $12.00. The Score for FBRX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
FBRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals [NBY] share price is $0.66. The Score for NBY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FBRX Stock Price Chart
What is Forte Biosciences's stock price today?
-
The Forte Biosciences share price today is $12.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FBRX is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.66Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.
FBRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.72 | Sell |
Relative Strength Index (14 RSI): | 36.84 | Sell |
Chaikin Money Flow: | -2711 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.51 - 16.35) | Sell |
Bollinger Bands (100): | (5.48 - 19.98) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 49.43 | Sell |
Chaikin Money Flow: | 34267 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.65 - 0.73) | Sell |
Bollinger Bands (100): | (0.58 - 0.72) | Buy |
FBRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.02 | Sell |
20-day SMA: | 14.01 | Sell |
50-day SMA: | 18.28 | Sell |
200-day SMA: | 12.65 | Sell |
8-day EMA: | 12.16 | Sell |
20-day EMA: | 13.9 | Sell |
50-day EMA: | 15.18 | Sell |
200-day EMA: | 14.15 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.67 | Sell |
20-day SMA: | 0.68 | Sell |
50-day SMA: | 0.63 | Buy |
200-day SMA: | 1.32 | Sell |
8-day EMA: | 0.66 | Sell |
20-day EMA: | 0.67 | Sell |
50-day EMA: | 0.66 | Sell |
200-day EMA: | 3.48 | Sell |
Forte Biosciences Earnings Growth & FBRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $6.61 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.36 per share, and an increase next year of $0.99 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.
Forte Biosciences Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |